neoplasms, plasma cell
Showing 1 - 5 of 5
Multiple Myeloma, Multiple Myeloma in Relapse, Tumors Trial (Belantamab Mafodotin-Blmf, Daratumumab, Pomalidomide)
Not yet recruiting
- Multiple Myeloma
- +8 more
- Belantamab Mafodotin-Blmf
- +3 more
- (no location specified)
Oct 13, 2022
Multiple Myeloma, Tumors, Tumors, Plasma Cell Trial (Belantamab Mafodotin-Blmf, Daratumumab, Lenalidomide)
Not yet recruiting
- Multiple Myeloma
- +7 more
- Belantamab Mafodotin-Blmf
- +3 more
- (no location specified)
Mar 4, 2022
Ninlaro Intensive Drug Monitoring Protocol
Recruiting
- Multiple Myeloma
- Neoplasms, Plasma Cell
-
Hefei, Anhui, China
- +27 more
Feb 24, 2022